QGEN Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: FDA approvals and strategic partnerships bolster QGEN's market position, with promising diagnostic product growth.




Bearish Case: Ongoing legal challenges and high volatility pose risks, potentially exacerbating investor skepticism and price pressure.




Potential Outcomes:
  • 60%: Strategic growth in diagnostics boosts revenues.
  • 50%: Legal disputes hinder performance.
  • 40%: Market skepticism continues.



March 22, 2025


Qiagen Forecast

QGEN        Qiagen











Correlated Assets

Assets that tend to move strongly with QGEN



SG Forecast + Options Trading Strategies   SG  Sweetgreen (0.53)


NWL Forecast + Options Trading Strategies   NWL  Newell Brands (0.52)


UNH Forecast + Options Trading Strategies   UNH  Unitedhealth (0.49)


AEHR Forecast + Options Trading Strategies   AEHR  Aehr Test Systems (0.47)


PHM Forecast + Options Trading Strategies   PHM  PulteGroup (0.44)



Uncorrelated Assets

Assets with little price relationship to QGEN



CNI Forecast + Options Trading Strategies   CNI  Canadian National Railway (0.0)


LMND Forecast + Options Trading Strategies   LMND  Lemonade (-0.0)


BIIB Forecast + Options Trading Strategies   BIIB  Biogen (0.01)


COTY Forecast + Options Trading Strategies   COTY  Coty (0.01)


ARWR Forecast + Options Trading Strategies   ARWR  Arrowhead Pharmaceuticals (-0.01)



Anticorrelated Assets

Assets that tend to move strongly against QGEN



CRSR Forecast + Options Trading Strategies   CRSR  Corsair Gaming (-0.47)


HES Forecast + Options Trading Strategies   HES  Hess (-0.47)


ETR Forecast + Options Trading Strategies   ETR  Entergy (-0.47)


AIG Forecast + Options Trading Strategies   AIG  American International (-0.49)


TAL Forecast + Options Trading Strategies   TAL  TAL Education (-0.54)









Become a more profitable investor with AI optimized trading strategies






×

Chat with QGEN


 Ask any question about QGEN!